GALE (NM_000403) Human Recombinant Protein
CAT#: TP720236
Recombinant protein of human UDP-galactose-4-epimerase (GALE), transcript variant 1
View other "GALE" proteins (12)
Need it in bulk or customized? Get a free quote |
CNY 1,800.00
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Species | Human |
Expression cDNA Clone or AA Sequence |
Met1-Ala348
|
Tag | N-His |
Predicted MW | 40.4 kDa |
Concentration | lot specific |
Purity | >95% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | Supplied as a 0.2 um filtered solution of 50mM Tris-HCl, 150mM NaCl, 2mM DTT, 1mM EDTA, pH 8.0. |
Storage | Store at < -20°C, stable for 6 months after receipt. Please minimize freeze-thaw cycles. |
Stability | Stable for at least 3 months from date of receipt under proper storage and handling conditions. |
Endotoxin | < 0.1 EU per µg protein as determined by LAL test |
Reference Data | |
RefSeq | |
Locus ID | 2582 |
UniProt ID | Q14376 |
Cytogenetics | 1p36.11 |
Synonyms | SDR1E1 |
Summary | This gene encodes UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and cognitive disability, with symptoms ranging from mild ('peripheral' form) to severe ('generalized' form). Multiple alternatively spliced transcripts encoding the same protein have been identified. [provided by RefSeq, Jul 2008] |
Protein Families | Druggable Genome |
Protein Pathways | Amino sugar and nucleotide sugar metabolism, Galactose metabolism, Metabolic pathways |
Documents
FAQs |
SDS |
Resources
蛋白相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
LC423394 | GALE HEK293T cell transient overexpression lysate (as WB positive control) |
CNY 900.00 |
|
LC424739 | GALE HEK293T cell transient overexpression lysate (as WB positive control) |
CNY 900.00 |
|
LC426826 | GALE HEK293T cell transient overexpression lysate (as WB positive control) |
CNY 900.00 |
|
LY423394 | Transient overexpression lysate of UDP-galactose-4-epimerase (GALE), transcript variant 2 |
CNY 3,080.00 |
|
LY424739 | Transient overexpression lysate of UDP-galactose-4-epimerase (GALE), transcript variant 1 |
CNY 3,080.00 |
|
LY426826 | Transient overexpression lysate of UDP-galactose-4-epimerase (GALE), transcript variant 3 |
CNY 3,080.00 |
|
PH301561 | GALE MS Standard C13 and N15-labeled recombinant protein (NP_000394) |
CNY 19,520.00 |
|
PH308709 | GALE MS Standard C13 and N15-labeled recombinant protein (NP_001008217) |
CNY 19,520.00 |
|
PH325521 | GALE MS Standard C13 and N15-labeled recombinant protein (NP_001121093) |
CNY 19,520.00 |
|
TP301561 | Recombinant protein of human UDP-galactose-4-epimerase (GALE), transcript variant 1, 20 µg |
CNY 2,900.00 |
|
TP308709 | Recombinant protein of human UDP-galactose-4-epimerase (GALE), transcript variant 2, 20 µg |
CNY 2,900.00 |
|
TP325521 | Recombinant protein of human UDP-galactose-4-epimerase (GALE), transcript variant 3, 20 µg |
CNY 2,900.00 |